medac GmbH
Dr. Florian Ende has extensive work experience in the pharmaceutical industry. Dr. Florian began their career at medac GmbH in 2001 as a Mitarbeiter Analytische Entwicklung and later progressed to become the Laborleiter Qualitätskontrolle, and then the Leiter der Qualitätskontrolle. In 2007, they took on the role of Leiter Qualitätsmanagement and held this position until 2012. From 2008 to 2018, Dr. Ende served as the Vice President Quality at medac GmbH. Currently, they hold the position of Vice President Product Development, starting in October 2018.
Prior to their work at medac GmbH, Dr. Ende worked as a Wissenschaftlicher Mitarbeiter at Universität Hamburg from 1998 to 2000. Additionally, they gained experience in the entertainment industry, working as a Darsteller in verschiedene ZDF-Kinderfernsehproduktionen at Televersal Filmgesellschaft from 1997 to 2002.
Dr. Florian Ende's education history is as follows:
In 1991, Dr. Ende enrolled at the University of Hamburg, where they pursued a degree in Chemistry. Dr. Florian completed their studies and obtained a Diplom in Chemistry in 1997.
Afterward, they continued their academic journey at the same university and specialized in Organic Chemistry. Dr. Ende pursued a doctoral degree and successfully obtained a Dr. rer. nat. in Organic Chemistry in 2000.
In 2017, Dr. Ende attended the Metaplan Leadership & Organization Academy, where they completed the Metaplan Professional program in 2018.
Overall, Dr. Florian Ende's educational background includes a Diplom in Chemistry from the University of Hamburg, a doctoral degree in Organic Chemistry, and further academic development through the Metaplan Leadership & Organization Academy.
medac GmbH
We are a privately held, medium-sized global pharmaceutical and diagnostics company based in Germany. For more than 50 years we have been committed to high quality products, reliable supply and individual customer services. Today, over 2.000 medac employees worldwide are working together to supply more than 90 countries with our products. Since our foundation we have been specialising in the treatment of oncological, haematological, urological, and autoimmune diseases. Today, we are a leading specialist supplier in oncology and rheumatology. We combine the innovative power of a researching pharmaceutical company with the efficiency of a generics manufacturer and offer both therapeutics and diagnostics. Always putting the needs of patients and healthcare professionals first, we are committed to the refinement of established and the development of new products with additional benefits for patients in specific niche indications with high therapeutic needs.